| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 15.138 | 21.017 | 15.074 | 19.936 | 27.570 | 31.232 | 32.664 |
| Total Income - EUR | - | - | - | 15.138 | 21.017 | 15.074 | 19.936 | 27.570 | 31.232 | 32.664 |
| Total Expenses - EUR | - | - | - | 2.067 | 1.829 | 1.646 | 2.065 | 1.910 | 9.874 | 12.734 |
| Gross Profit/Loss - EUR | - | - | - | 13.070 | 19.188 | 13.428 | 17.872 | 25.660 | 21.358 | 19.930 |
| Net Profit/Loss - EUR | - | - | - | 12.709 | 18.557 | 13.010 | 17.345 | 25.082 | 21.093 | 19.058 |
| Employees | - | - | - | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Anco Medex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 12.927 | 31.229 | 43.584 | 60.068 | 85.163 | 101.770 | 106.420 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 1.043 | 750 | 867 | 952 | 101.463 | 101.514 |
| Cash | - | - | - | 12.927 | 30.185 | 42.833 | 59.200 | 84.211 | 307 | 4.906 |
| Shareholders Funds | - | - | - | 12.752 | 31.063 | 43.483 | 59.864 | 85.132 | 101.519 | 104.933 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 175 | 166 | 100 | 203 | 31 | 250 | 1.487 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Anco Medex S.r.l.